<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Magnetic seizure therapy for people with schizophrenia - Wu, H - 2023 | Cochrane Library</title> <meta content="Magnetic seizure therapy for people with schizophrenia - Wu, H - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012697.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Magnetic seizure therapy for people with schizophrenia - Wu, H - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012697.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012697.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Magnetic seizure therapy for people with schizophrenia" name="citation_title"/> <meta content="Hui Wu" name="citation_author"/> <meta content="Jiangling Jiang" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Xinyi Cao" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Jijun Wang" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Chunbo Li" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="licb@smhc.org.cn" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD012697.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/06/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012697.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012697.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012697.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Antipsychotic Agents [adverse effects]; Memory Disorders; *Schizophrenia [drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012697.pub2&amp;doi=10.1002/14651858.CD012697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="XHP2gG4h";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012697\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012697\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","pt","ms","ja","fa","id","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012697.pub2",title:"Magnetic seizure therapy for people with schizophrenia",firstPublishedDate:"Jun 5, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012697.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012697.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012697.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012697.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012697.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012697.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012697.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012697.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012697.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012697.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1776 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012697.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0158"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0099"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-sec-0152"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/supinfo/CD012697-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/supinfo/CD012697-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Magnetic seizure therapy for people with schizophrenia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#CD012697-cr-0004">Hui Wu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#CD012697-cr-0005">Jiangling Jiang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#CD012697-cr-0006">Xinyi Cao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#CD012697-cr-0007">Jijun Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information#CD012697-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Chunbo Li</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information/en#CD012697-sec-0165">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 June 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012697.pub2">https://doi.org/10.1002/14651858.CD012697.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012697-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012697-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012697-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012697-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012697-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012697-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012697-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012697-abs-0001" lang="en"> <section id="CD012697-sec-0001"> <h3 class="title" id="CD012697-sec-0001">Background</h3> <p>Schizophrenia is one of the most common and disabling mental disorders. About 20% of people with schizophrenia do not respond to antipsychotics, which are the mainstay of the treatment for schizophrenia today, and need to seek other treatment options. Magnetic seizure therapy (MST) is one of the novel non‐invasive brain stimulation techniques that are being investigated in recent years.  </p> </section> <section id="CD012697-sec-0002"> <h3 class="title" id="CD012697-sec-0002">Objectives</h3> <p>To evaluate the efficacy and tolerability of MST for people with schizophrenia.</p> </section> <section id="CD012697-sec-0003"> <h3 class="title" id="CD012697-sec-0003">Search methods</h3> <p>On 6 March 2022, we searched the Cochrane Schizophrenia Group's Study‐Based Register of Trials which is based on CENTRAL, CINAHL, ClinicalTrials.Gov, Embase, ISRCTN, MEDLINE, PsycINFO, PubMed, and WHO ICTRP. </p> </section> <section id="CD012697-sec-0004"> <h3 class="title" id="CD012697-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) comparing MST alone or plus standard care with ECT or any other interventions for people with schizophrenia.  </p> </section> <section id="CD012697-sec-0005"> <h3 class="title" id="CD012697-sec-0005">Data collection and analysis</h3> <p>We performed reference screening, study selection, data extraction and risk of bias and quality assessment in duplicate. We calculated the risk ratios (RRs) and their 95% confidence intervals (CIs) for binary outcomes and the mean difference (MD) and their 95% CIs for continuous outcomes. We used the original risk of bias tool for risk of bias assessment and created a Summary of findings table using GRADE. </p> </section> <section id="CD012697-sec-0006"> <h3 class="title" id="CD012697-sec-0006">Main results</h3> <p>We included one four‐week study with 79 adults in acute schizophrenia, comparing MST plus standard care to ECT plus standard care in this review. We rated the overall risk of bias as high due to high risk of bias in the domains of selective reporting and other biases (early termination and baseline imbalance) and unclear risk of bias in the domain of blinding of participants and personnel. </p> <p>We found that MST and ECT may not differ in improving the global state (n = 79, risk ratio (RR) 1.12, 95% confidence interval (CI) 0.73 to 1.70), overall (n = 79, mean difference (MD) ‐0.20, 95% CI ‐8.08 to 7.68), the positive symptoms (n = 79, MD 1.40, 95% CI ‐1.97 to 4.77) and the negative symptoms (n = 79, MD ‐1.00, 95% CI ‐3.85 to 1.85) in people with schizophrenia.  </p> <p>We found  that MST compared to ECT may cause less delayed memory deficit and less cognitive deterioration (n = 79, number of people with a delayed memory deficit, RR 0.63, 95% CI 0.41 to 0.96; n = 79, mean change in global cognitive function, MD 5.80, 95% CI 0.80 to 10.80), but also may improve more cognitive function (n = 47, number of people with any cognitive improvement, RR 3.30, 95% CI 1.29 to 8.47).  </p> <p>We found that there may be no difference between the two groups in terms of leaving the study early due to any reason (n = 79, RR 2.51, 95% CI 0.73 to 8.59), due to adverse effects (n = 79, RR 3.35, 95% CI 0.39 to 28.64) or due to inefficacy (n = 79, RR 2.52, 95% CI 0.11 to 60.10).  </p> <p>Since all findings were based on one study with high risk of bias and the confidence in the evidence was very low, we were not sure these comparable or favourable effects of MST over ECT were its true effects.  </p> </section> <section id="CD012697-sec-0007"> <h3 class="title" id="CD012697-sec-0007">Authors' conclusions</h3> <p>Due to the paucity of data, we cannot draw any conclusion on the efficacy and tolerability of MST for people with schizophrenia. Well‐designed RCTs are warranted to answer the question. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012697-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012697-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012697-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012697-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012697-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD012697-abs-0013">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012697-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012697-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012697-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012697-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012697-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012697-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012697-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012697-abs-0002" lang="en"> <h3>What are the benefits and risks of magnetic seizure therapy for people with schizophrenia?</h3> <p><b>Key messages</b> </p> <p>There were too scarce data to evaluate the benefits and risks of magnetic seizure therapy (MST) for people with schizophrenia. </p> <p>We need more and better studies to look into this.</p> <p><b>What is schizophrenia?</b> </p> <p>Schizophrenia is one of the most common and disabling mental disorders. People with schizophrenia may have difficulties living a normal life due to the illness, which may include distorted beliefs despite reality, hearing voices created by their minds, and having no interest in caring for others or themselves. </p> <p><b>Why is this important for people with schizophrenia?</b> </p> <p>Most people with schizophrenia receive antipsychotic treatments. For those who don't respond well to antipsychotics or wish to use alternative treatments, electroconvulsive therapy (ECT) could be an effective and safe choice. This therapy causes a seizure in an anaesthetised person by electric currents applied to the brain; in this way, psychotic symptoms are improved or relieved. However, ECT has side effects such as temporary memory loss, and confusion after treatments, which limits its use. Magnetic seizure therapy is one of the novel non‐invasive brain stimulation techniques, which works like ECT by inducing a seizure, however not with electric currents but with magnetic energy fields, which theoretically would cause less risk of memory loss or confusion after the treatments. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know whether MST helps people with schizophrenia.</p> <p>We were interested in:</p> <p>‐ number of people with symptoms improved;</p> <p>‐ number of people with impaired cognitive function;</p> <p>‐ number of people with clinically important side effects.</p> <p><b>What did we do?</b> </p> <p>We searched for studies that investigated the effect of MST compared to any other treatments for people with schizophrenia.  </p> <p>We compared and summarised the results of the study and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p><b>Main results</b> </p> <p>We found one short‐term randomised controlled trial (RCT) with 79 adults that met the review requirements. It compared MST plus standard care to ECT plus standard care. Our findings were based on very limited data. We found that MST and ECT may be comparable in improving the global state of people with schizophrenia, and in improving the overall, positive and negative symptoms of schizophrenia. MST may cause less delayed memory deficit and less cognitive deterioration and may improve cognitive function compared to ECT. There may be no difference between the two groups in terms of leaving the study early due to any reason, adverse effects, or inefficacy. We cannot conclude whether MST is helpful or safe for people with schizophrenia based on limited data. Well‐designed RCTs are warranted to answer the question. </p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>The evidence is up‐to‐date to 06 March 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012697-sec-0158" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012697-sec-0158"></div> <h3 class="title" id="CD012697-sec-0159">Implications for practice</h3> <section id="CD012697-sec-0159"> <p>MST as novel non‐invasive brain stimulation was developed to be an alternative to current treatment options for schizophrenia. However, no recommendations for this new therapy can be given before a proper assessment is available. Data were too scarce to draw any useful conclusions for people with schizophrenia, clinicians, and policy‐makers. MST has been more often investigated in people with depression but, unfortunately, there is still insufficient information on its efficacy and tolerability in such a group of people (<a href="./references#CD012697-bbs2-0044" title="JiangJ , ZhangC , LiC , ChenZ , CaoX , WangH , et al. Magnetic seizure therapy for treatment‐resistant depression. Cochrane Database of Systematic Reviews2021, Issue 6. Art. No: CD013528. [DOI: 10.1002/14651858.CD013528.pub2]">Jiang 2021</a>), underscoring the overall limited evidence we have about MST. Those who wish to use MST should bear the unknown risk in mind. Cautions should be taken before application.  </p> </section> <h3 class="title" id="CD012697-sec-0160">Implications for research</h3> <section id="CD012697-sec-0160"> <p>There is a significant lack of evidence in this field. Preliminary findings showed MST could have good efficacy and result in minimal cognitive impairment for acute treatment in depression (<a href="./references#CD012697-bbs2-0012" title="CretazE , BrunoniAR , LaferB . Magnetic seizure therapy for unipolar and bipolar depression: a systematic review. Neural Plasticity2015;2015:521398.">Cretaz 2015</a>; <a href="./references#CD012697-bbs2-0016" title="DaskalakisZJ , DimitrovaJ , McClintockSM , SunY , VoineskosD , RajjiTK , et al. Magnetic seizure therapy (MST) for major depressive disorder. Neuropsychopharmacology2020;45(2):276-82.">Daskalakis 2020</a>; <a href="./references#CD012697-bbs2-0068" title="MutzJ , VipulananthanV , CarterB , HurlemannR , FuCHY , YoungAH . Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. British Medical Journal2019;364:l1079.">Mutz 2019</a>). However, the findings lacked not only precision but also consistency, similar to the findings of the evidence in people with schizophrenia. More investigation is needed to answer the question with certainty, and emphasis should be put on cognitive function evaluation with regard to the side effects profile.  </p> <p>To assess the effect of MST, studies with a longer duration are needed, as well as studies of people with stable schizophrenia for a relapse prevention purpose.   </p> <p>The only included study was terminated due to coil malfunction, which leads to the question whether MST is cost‐effective. To assess whether MST is a good alternative to other treatment options, an economic assessment is necessary for inclusion in future studies. </p> <p>Regardless of the limited data, current evidence could not exclude the potential for MST to be a promising treatment alternative that may have desirable efficacy and a benign side effect profile for people with schizophrenia. Well‐designed RCTs are needed to inform clinical practice about the efficacy and tolerability of MST in people with schizophrenia. The optimal information size should be met to provide good precision and efforts should be made to undertake blinding to avoid bias. However, due to the nature of MST, it is difficult to conduct such RCTs. Good reporting is also essential to allow adequate evaluation of the evidence. The CONSORT Statement (available at <a href="https://www.consort-statement.org" target="_blank">www.consort-statement.org</a>) should be complied with. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012697-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012697-sec-0008"></div> <div class="table" id="CD012697-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute schizophrenia<br/><b>Setting:</b> inpatient<br/><b>Intervention:</b> magnetic seizure therapy + standard care<br/><b>Comparison:</b> electroconvulsive therapy + standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with electroconvulsive therapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with magnetic seizure therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: clinically important change <br/>assessed by: number of participants with a clinical response<br/>Study duration: 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.12<br/>(0.73 to 1.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>A clinical response was defined as a ≥ 25% reduction from baseline to the endpoint of the PANSS total score. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>472 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000<br/>(345 to 803) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive functioning: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effects: clinically important adverse effects<br/>assessed by: number of participants with a delayed memory deficit<br/>Study duration: 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.41 to 0.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>A delayed memory deficit was defined as a ≥ 10% decrease from baseline to the endpoint of the RBANS delayed memory score. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>667 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>420 per 1000<br/>(273 to 640) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social functioning: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Leaving the study early: any reason<br/>assessed by: number of dropouts for any reason </p> <p>Study duration: 4 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.51<br/>(0.73 to 8.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/>(61 to 716) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PANSS</b> : the Positive and Negative Syndrome Scale; <b>RBANS</b> : the Repeatable Battery for the Assessment of Neuropsychological Status; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by two levels: high risk of bias in two domains (selective reporting, other bias) and unclear risk in one domain (blinding of participants and personnel). </p> <p><sup>2</sup> Downgraded by two levels: the optimal information size (OIS) was not met and the confidence interval included both appreciable benefit and harm. </p> <p><sup>3</sup> Downgraded by one level: OIS was not met. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012697-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012697-sec-0009"></div> <section id="CD012697-sec-0010"> <h3 class="title" id="CD012697-sec-0010">Description of the condition</h3> <p>Schizophrenia is one of the most common mental disorders; its lifetime morbid risk is estimated to be 1% with no gender difference (<a href="./references#CD012697-bbs2-0065" title="McGrathJ , SahaS , ChantD , WelhamJ . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews2008;30:67-76. [PMID: 18480098]">McGrath 2008</a>). The mean age of onset is about 25 years old (<a href="./references#CD012697-bbs2-0083" title="SolmiM , RaduaJ , OlivolaM , CroceE , SoardoL , Salazar de PabloG , et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Molecular Psychiatry2022;27(1):281-95.">Solmi 2022</a>) with generally earlier onset in men than in women (<a href="./references#CD012697-bbs2-0071" title="OchoaS , UsallJ , CoboJ , LabadX , KulkarniJ . Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophrenia Research and Treatment2012;2012:916198.">Ochoa 2012</a>). Clinical presentation is diversified and principal features include positive symptoms (e.g. delusions, hallucinations, disorganised speech), negative symptoms (e.g. affective flattening, alogia, avolition) and cognitive impairment (<a href="./references#CD012697-bbs2-0086" title="TandonR , GaebelW , BarchDM , BustilloJ , GurRE , HeckersS , et al. Definition and description of schizophrenia in the DSM-5. Schizophrenia Research2013;150(1):3-10. [PMID: 23800613]">Tandon 2013</a>). Diagnosis is built on history and mental state examination (<a href="./references#CD012697-bbs2-0073" title="OwenMJ , SawaA , MortensenPB . Schizophrenia. Lancet2016;388(10039):86-97. [PMID: 26777917]">Owen 2016</a>) using operationalised criteria from manuals such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) (<a href="./references#CD012697-bbs2-0006" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Arlington, VA: American Psychiatric Publishing, 2013.">APA 2013</a>) and the WHO International Classification of Diseases (ICD) (<a href="./references#CD012697-bbs2-0093" title="WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.">WHO 1992</a>). This psychopathology causes deterioration of functioning over time and is described as a highly disabling condition, which makes it a heavy burden on individuals, families and society. It is the twentieth leading cause of disability worldwide in 2019 according to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 (<a href="./references#CD012697-bbs2-0032" title="GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry2022;9(2):137-150. [DOI: https://doi.org/10.1016/S2215-0366(21)00395-3]">GBD 2019</a>).  </p> <p>The main treatment plan for schizophrenia is antipsychotic medications combined with psychosocial interventions and rehabilitation (<a href="./references#CD012697-bbs2-0051" title="LehmanAF , LiebermanJA , DixonLB , McGlashanTH , MillerAL , PerkinsDO , et al. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry2004;161(2 Suppl):1-56. [PMID: 15000267]">Lehman 2004</a>; <a href="./references#CD012697-bbs2-0073" title="OwenMJ , SawaA , MortensenPB . Schizophrenia. Lancet2016;388(10039):86-97. [PMID: 26777917]">Owen 2016</a>). Antipsychotics remain the mainstay of the treatments for schizophrenia (<a href="./references#CD012697-bbs2-0073" title="OwenMJ , SawaA , MortensenPB . Schizophrenia. Lancet2016;388(10039):86-97. [PMID: 26777917]">Owen 2016</a>). However, about 20% of people with schizophrenia do not respond to antipsychotics (<a href="./references#CD012697-bbs2-0062" title="MarderSR , AmesD , WirshingWC , Van PuttenT . Schizophrenia. Psychiatric Clinics of North America1993;16(3):567-87. [PMID: 8105452]">Marder 1993</a>; <a href="./references#CD012697-bbs2-0078" title="Samara MT , NikolakopoulouA , SalantiG , LeuchtS . How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials. Schizophrenia Bulletin2019;45(3):639-46.">Samara 2019</a>) and need to seek other treatment options. One such treatment is electroconvulsive therapy (ECT). People with schizophrenia receive ECT treatment because of unpleasant side effects and unsatisfactory efficacy of medications, anticipation of or need for rapid response, or personal preference (<a href="./references#CD012697-bbs2-0005" title="American Psychiatric Association. The practice of ECT: recommendations for treatment, training and privileging. Convulsive Therapy1990;6(2):85-120. [PMID: 11659302]">APA 1990</a>; <a href="./references#CD012697-bbs2-0089" title="TharyanP , AdamsCE . Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews2005, Issue 2. Art. No: CD000076. [DOI: 10.1002/14651858.CD000076.pub2] [PMID: 15846598]">Tharyan 2005</a>; <a href="./references#CD012697-bbs2-0092" title="WeissA , HussainS , NgB , SarmaS , TillerJ , WaiteS , et al. Royal Australian and New Zealand college of psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Australian and New Zealand Journal of Psychiatry2019;53(7):609-23.">Weiss 2019</a>). </p> <p>Major depression is the main indication for ECT in the United States, Australia, and European countries (<a href="./references#CD012697-bbs2-0010" title="ChanpattanaW . A questionnaire survey of ECT practice in Australia. Journal of Electroconvulsive Therapy2007;23(2):89-92. [PMID: 17548977]">Chanpattana 2007</a>; <a href="./references#CD012697-bbs2-0066" title="MoksnesKM , IlnerSO . Electroconvulsive therapy - efficacy and side-effects. Tidsskrift for Den Norske Laegeforening2010;130(24):2460-4. [PMID: 21164584]">Moksnes 2010</a>; <a href="./references#CD012697-bbs2-0067" title="MowlaA , SahraianA , HushmandF , HushmandF . Study the utilization and practice of ECT in South of Iran. Asian Journal of Psychiatry2015;14:65-6. [DOI: 10.1016/j.ajp.2015.02.002]">Mowla 2015</a>) while schizophrenia is the most common indication in Asia (<a href="./references#CD012697-bbs2-0009" title="ChanpattanaW , KojimaK , KramerBA , IntakornA , SasakiS , KitphatiR . ECT practice in Japan. Journal of Electroconvulsive Therapy2005;21(3):139-44. [PMID: 16127301]">Chanpattana 2005</a>; <a href="./references#CD012697-bbs2-0011" title="ChanpattanaW , KramerBA , KunigiriG , GangadharBN , KitphatiR , AndradeC . A survey of the practice of electroconvulsive therapy in Asia. Journal of Electroconvulsive Therapy2010;26(1):5-10. [PMID: 19444137]">Chanpattana 2010</a>). ECT has been widely used in China since its introduction in the 1950s for the treatment of schizophrenia (<a href="./references#CD012697-bbs2-0087" title="TangYL , JiangW , RenYP , MaX , CotesRO , McDonaldWM . Electroconvulsive therapy in China: clinical practice and research on efficacy. Journal of Electroconvulsive Therapy2012;28(4):206-12. [PMID: 22801297]">Tang 2012</a>). The usage rate of ECT for schizophrenia increased over the past decade in China while remaining low and relatively stable in other Asian countries (<a href="./references#CD012697-bbs2-0095" title="XiangYT , UngvariGS , CorrellCU , ChiuHF , LaiKY , WangCY , et al. Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): trends and correlates. Psychiatry and Clinical Neurosciences2015;69(8):489-96. [PMID: 25708964]">Xiang 2015</a>). The popularity of ECT in developed countries such as the United States and United Kingdom has declined since concerns about cognitive side effects arose (<a href="./references#CD012697-bbs2-0003" title="AllanCL , EbmeierKP . The use of ECT and MST in treating depression. International Review of Psychiatry2011;23(5):400-12. [PMID: 22200130]">Allan 2011</a>). </p> </section> <section id="CD012697-sec-0011"> <h3 class="title" id="CD012697-sec-0011">Description of the intervention</h3> <p>Since the introduction of ECT as a therapeutic method for schizophrenia in 1934, it has played an important role in the treatment for schizophrenia for over 70 years (<a href="./references#CD012697-bbs2-0027" title="EitanR , LererB . Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues in Clinical Neuroscience2006;8(2):241-58. [PMID: 16889109]">Eitan 2006</a>). ECT is the only non‐pharmacological physical treatment option for schizophrenia approved by the U.S. Food and Drug Administration (FDA) (<a href="./references#CD012697-bbs2-0091" title="WeinerR , LisanbySH , HusainMM , MoralesOG , MaixnerDF , HallSE , et al. Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations. Journal of Clinical Psychiatry2013;74(1):38-42. [PMID: 23419224]">Weiner 2013</a>). It is also widely used for other psychiatric conditions such as major depressive disorder (MDD), bipolar disorder (BPD), catatonia, and schizoaffective disorder (<a href="./references#CD012697-bbs2-0073" title="OwenMJ , SawaA , MortensenPB . Schizophrenia. Lancet2016;388(10039):86-97. [PMID: 26777917]">Owen 2016</a>). Advances in anaesthesiology have greatly improved the safety and tolerability of ECT, however post‐ictal confusion, attention deficiency, and transient memory disturbance are often problematic and affect treatment compliance (<a href="./references#CD012697-bbs2-0039" title="Holtzheimer PE 3rd, NemeroffCB . Advances in the treatment of depression. NeuroRx2006;3(1):42-56. [PMID: 16490412]">Holtzheimer 2006</a>; <a href="./references#CD012697-bbs2-0041" title="HoyKE , FitzgeraldPB . Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices2011;8(6):723-32. [PMID: 22029469]">Hoy 2011</a>; <a href="./references#CD012697-bbs2-0058" title="LisanbySH , LuberB , SchlaepferTE , SackeimHA . Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology2003;28(10):1852-65. [PMID: 12865903]">Lisanby 2003a</a>). Attempts to improve the efficacy and side effect profile of ECT can be made by using alternative electrode placements, variations in stimulus configuration and focal electrical stimulation. Novel developments such as magnetic seizure therapy (MST) are also used (<a href="./references#CD012697-bbs2-0027" title="EitanR , LererB . Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues in Clinical Neuroscience2006;8(2):241-58. [PMID: 16889109]">Eitan 2006</a>; <a href="./references#CD012697-bbs2-0059" title="LisanbySH , MoralesO , PayneN , KwonE , FitzsimonsL , LuberB , et al. New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectrums2003;8(7):529-36. [PMID: 12894034]">Lisanby 2003b</a>; <a href="./references#CD012697-bbs2-0060" title="LooCK , SchweitzerI , PrattC . Recent advances in optimizing electroconvulsive therapy. Australian and New Zealand Journal of Psychiatry2006;40(8):632-8. [PMID: 16866758]">Loo 2006</a>) </p> <p>MST is a promising alternative to ECT that, for now, is only used for research purposes. MST is a noninvasive, physical treatment, developed as an improvement over conventional convulsive therapies (<a href="./references#CD012697-bbs2-0056" title="LisanbySH , LuberB , FinckAD , SchroederC , SackeimHA . Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry2001;58(2):199-200. [PMID: 11177122]">Lisanby 2001b</a>). It combines the characteristics of both ECT and repetitive transcranial magnetic stimulation (rTMS). MST generates electromagnetic stimulation by rapidly alternating magnetic fields like rTMS but in a more intensive way (<a href="./references#CD012697-bbs2-0056" title="LisanbySH , LuberB , FinckAD , SchroederC , SackeimHA . Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry2001;58(2):199-200. [PMID: 11177122]">Lisanby 2001b</a>; <a href="./references#CD012697-bbs2-0057" title="LisanbySH . Update on magnetic seizure therapy: a novel form of convulsive therapy. Journal of Electroconvulsive Therapy2002;18(4):182-8. [PMID: 12468992]">Lisanby 2002</a>) and induces a seizure to alleviate symptoms (<a href="./references#CD012697-bbs2-0076" title="RauA , GrossheinrichN , PalmU , PogarellO , PadbergF . Transcranial and deep brain stimulation approaches as treatment for depression. Clinical EEG and Neuroscience2007;38(2):105-15. [PMID: 17515176]">Rau 2007</a>). </p> <p>MST is conducted under general anaesthesia, requiring short‐acting anaesthetics and muscle relaxants (<a href="./references#CD012697-bbs2-0056" title="LisanbySH , LuberB , FinckAD , SchroederC , SackeimHA . Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry2001;58(2):199-200. [PMID: 11177122]">Lisanby 2001b</a>; <a href="./references#CD012697-bbs2-0089" title="TharyanP , AdamsCE . Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews2005, Issue 2. Art. No: CD000076. [DOI: 10.1002/14651858.CD000076.pub2] [PMID: 15846598]">Tharyan 2005</a>). A twin coil held at the vertex (or sometimes a figure eight coil on the right prefrontal cortex) generates magnetic fields and forms an indirect electric current in the brain, which induces a seizure when it exceeds the individual seizure threshold (<a href="./references#CD012697-bbs2-0029" title="FitzgeraldPB , HoyKE , HerringSE , ClintonAM , DowneyG , DaskalakisZJ . Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety2013;30(2):129-36. [PMID: 23080404]">Fitzgerald 2013</a>; <a href="./references#CD012697-bbs2-0040" title="HoyKE , FitzgeraldPB . Introducing magnetic seizure therapy: a novel therapy for treatment resistant depression. Australian and New Zealand Journal of Psychiatry2010;44(7):591-8. [PMID: 20560846]">Hoy 2010</a>; <a href="./references#CD012697-bbs2-0049" title="KayserS , BewernickBH , MatuschA , HurlemannR , SoehleM , SchlaepferTE . Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychological Medicine2015;45(5):1073-92. [PMID: 25420474]">Kayser 2015</a>: <a href="./references#CD012697-bbs2-0055" title="LisanbySH , SchlaepferTE , FischHU , SackeimHA . Magnetic seizure therapy of major depression. Archives of General Psychiatry2001;58(3):303-5. [PMID: 11231838]">Lisanby 2001a</a>; <a href="./references#CD012697-bbs2-0056" title="LisanbySH , LuberB , FinckAD , SchroederC , SackeimHA . Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry2001;58(2):199-200. [PMID: 11177122]">Lisanby 2001b</a>; <a href="./references#CD012697-bbs2-0069" title="NodaY , DaskalakisZJ , DownarJ , CroarkinPE , FitzgeraldPB , BlumbergerDM . Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report. Neuropsychiatric Disease and Treatment2014;10:2049-55. [PMID: 25382978]">Noda 2014</a>; <a href="./references#CD012697-bbs2-0074" title="PolsterJD , KayserS , BewernickBH , HurlemannR , SchlaepferTE . Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. Journal of Electroconvulsive Therapy2015;31(1):13-9. [PMID: 24853650]">Polster 2015</a>). The magnetic seizure threshold is normally titrated at the first treatment session by ascending duration in train (<a href="./references#CD012697-bbs2-0029" title="FitzgeraldPB , HoyKE , HerringSE , ClintonAM , DowneyG , DaskalakisZJ . Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety2013;30(2):129-36. [PMID: 23080404]">Fitzgerald 2013</a>; <a href="./references#CD012697-bbs2-0041" title="HoyKE , FitzgeraldPB . Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices2011;8(6):723-32. [PMID: 22029469]">Hoy 2011</a>). Electroencephalograms (EEGs) are monitored and rated to ensure the required seizure (<a href="./references#CD012697-bbs2-0049" title="KayserS , BewernickBH , MatuschA , HurlemannR , SoehleM , SchlaepferTE . Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychological Medicine2015;45(5):1073-92. [PMID: 25420474]">Kayser 2015</a>) and precautions should be taken to prevent side effects. Earplugs are required for patients and staff present to prevent tinnitus or potential hearing damage (<a href="./references#CD012697-bbs2-0029" title="FitzgeraldPB , HoyKE , HerringSE , ClintonAM , DowneyG , DaskalakisZJ . Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety2013;30(2):129-36. [PMID: 23080404]">Fitzgerald 2013</a>) and a bite‐block should be used by patients to protect their teeth (<a href="./references#CD012697-bbs2-0041" title="HoyKE , FitzgeraldPB . Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices2011;8(6):723-32. [PMID: 22029469]">Hoy 2011</a>). Session arrangements are basically the same as in an ECT treatment plan, occurring twice a week for a period of five to six weeks (<a href="./references#CD012697-bbs2-0041" title="HoyKE , FitzgeraldPB . Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices2011;8(6):723-32. [PMID: 22029469]">Hoy 2011</a>; <a href="./references#CD012697-bbs2-0074" title="PolsterJD , KayserS , BewernickBH , HurlemannR , SchlaepferTE . Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. Journal of Electroconvulsive Therapy2015;31(1):13-9. [PMID: 24853650]">Polster 2015</a>). </p> </section> <section id="CD012697-sec-0012"> <h3 class="title" id="CD012697-sec-0012">How the intervention might work</h3> <p>The mechanism of the therapeutic effect of an induced‐seizure from brain stimulation is still unclear (<a href="./references#CD012697-bbs2-0082" title="SinghA , KarSK . How electroconvulsive therapy works?: understanding the neurobiological mechanisms. Clinical Psychopharmacology and Neuroscience2017;15(3):210-21.">Singh 2017</a>). The effect of ECT is affected by impedance of the scalp and skull. Impedance can elevate electrical intensity and influence current distribution which leads to less control over regional stimulation of the brain. The MST device is immune to impedance as it generates electromagnetic signals by rapidly alternating magnetic fields, so is not shunted into the scalp and cerebrospinal fluid and only affects cells to a depth of 2 cm below the scalp (<a href="./references#CD012697-bbs2-0027" title="EitanR , LererB . Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues in Clinical Neuroscience2006;8(2):241-58. [PMID: 16889109]">Eitan 2006</a>; <a href="./references#CD012697-bbs2-0055" title="LisanbySH , SchlaepferTE , FischHU , SackeimHA . Magnetic seizure therapy of major depression. Archives of General Psychiatry2001;58(3):303-5. [PMID: 11231838]">Lisanby 2001a</a>). Spherical model tests have shown that MST generates more focal and superficial stimulations than ECT (<a href="./references#CD012697-bbs2-0020" title="DengZD , LisanbySH , PeterchevAV . Effect of anatomical variability on neural stimulation strength and focality in electroconvulsive therapy (ECT) and magnetic seizure therapy (MST). Engineering in Medicine and Biology Society2009;2009:682-8. [PMID: 19964484]">Deng 2009</a>; <a href="./references#CD012697-bbs2-0021" title="DengZD , LisanbySH , PeterchevAV . Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. Journal of Neural Engineering2011;8(1):016007. [PMID: 21248385]">Deng 2011</a>). Due to its superficial and confined stimulation field, MST is thought to have less impact on deeper brain structures (<a href="./references#CD012697-bbs2-0024" title="DworkAJ , ArangoV , UnderwoodM , IlievskiB , RosoklijaG , SackeimHA , et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. American Journal of Psychiatry2004;161(3):576-8. [PMID: 14992989]">Dwork 2004</a>; <a href="./references#CD012697-bbs2-0025" title="DworkAJ , ChristensenJR , LarsenKB , ScaliaJ , UnderwoodMD , ArangoV , et al. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience2009;164(4):1557-64. [PMID: 19782728]">Dwork 2009</a>). Physiological findings in rhesus monkeys show that MST, compared to electroconvulsive shock (ECS, equivalence to human ECT), triggered remarkably less marked sympathetic and parasympathetic response (<a href="./references#CD012697-bbs2-0077" title="RownySB , CycowiczYM , McClintockSM , TruesdaleMD , LuberB , LisanbySH . Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model. NeuroImage2009;47(3):1086-91. [PMID: 19497373]">Rowny 2009</a>). </p> <p>EEG data also show that seizure characteristics in neurophysiology are different between a MST‐induced seizure and an ECS‐induced one. MST and ECS had some cross‐over in seizure expression, but MST had less marked expression and post‐ictal suppression than ECS (<a href="./references#CD012697-bbs2-0013" title="CycowiczYM , LuberB , SpellmanT , LisanbySH . Differential neurophysiological effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS) in non-human primates. Clinical EEG and Neuroscience2008;39(3):144-9. [PMID: 18751564]">Cycowicz 2008</a>). Further experiments demonstrated a link between ictal expression and cognitive side effects (<a href="./references#CD012697-bbs2-0014" title="CycowiczYM , LuberB , SpellmanT , LisanbySH . Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. Journal of Electroconvulsive Therapy2009;25(3):157-64. [PMID: 19300292]">Cycowicz 2009</a>). Animal studies and human trials have found a positive effect for MST on cognitive functions including less impaired spatial working memory (<a href="./references#CD012697-bbs2-0064" title="McClintockSM , DeWindNK , HusainMM , RownySB , SpellmanTJ , TerraceH , et al. Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy. International Journal of Neuropsychopharmacology2013;16(1):177-87. [PMID: 22217479]">McClintock 2013</a>), better completion of criteria tasks (<a href="./references#CD012697-bbs2-0084" title="SpellmanT , McClintockSM , TerraceH , LuberB , HusainMM , LisanbySH . Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biological Psychiatry2008;63(12):1163-70. [PMID: 18262171]">Spellman 2008</a>), less acute memory disruption (<a href="./references#CD012697-bbs2-0074" title="PolsterJD , KayserS , BewernickBH , HurlemannR , SchlaepferTE . Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. Journal of Electroconvulsive Therapy2015;31(1):13-9. [PMID: 24853650]">Polster 2015</a>), and shorter post‐ictal recovery and reorientation times (<a href="./references#CD012697-bbs2-0048" title="KayserS , BewernickBH , HurlemannR , SoehleM , SchlaepferTE . Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression. European Neuropsychopharmacology2013;23(11):1541-50. [PMID: 23820052]">Kayser 2013</a>) compared to ECS/ECT. </p> </section> <section id="CD012697-sec-0013"> <h3 class="title" id="CD012697-sec-0013">Why it is important to do this review</h3> <p>MST was first used in a study for treating a person with major depression in 2001 (<a href="./references#CD012697-bbs2-0055" title="LisanbySH , SchlaepferTE , FischHU , SackeimHA . Magnetic seizure therapy of major depression. Archives of General Psychiatry2001;58(3):303-5. [PMID: 11231838]">Lisanby 2001a</a>). Since then, an increasing number of studies have examined the antidepressant effect of MST for depression, and the results are promising (<a href="./references#CD012697-bbs2-0029" title="FitzgeraldPB , HoyKE , HerringSE , ClintonAM , DowneyG , DaskalakisZJ . Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety2013;30(2):129-36. [PMID: 23080404]">Fitzgerald 2013</a>; <a href="./references#CD012697-bbs2-0041" title="HoyKE , FitzgeraldPB . Magnetic seizure therapy for treatment-resistant depression. Expert Review of Medical Devices2011;8(6):723-32. [PMID: 22029469]">Hoy 2011</a>; <a href="./references#CD012697-bbs2-0047" title="KayserS , BewernickBH , GrubertC , HadrysiewiczBL , AxmacherN , SchlaepferTE . Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. Journal of Psychiatric Research2011;45(5):569-76. [PMID: 20951997]">Kayser 2011</a>; <a href="./references#CD012697-bbs2-0058" title="LisanbySH , LuberB , SchlaepferTE , SackeimHA . Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology2003;28(10):1852-65. [PMID: 12865903]">Lisanby 2003a</a>) but remain unclear (<a href="./references#CD012697-bbs2-0068" title="MutzJ , VipulananthanV , CarterB , HurlemannR , FuCHY , YoungAH . Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. British Medical Journal2019;364:l1079.">Mutz 2019</a>). However, for schizophrenia, there is a paucity of evidence. It remains a question whether MST is more or less efficacious than ECT (<a href="./references#CD012697-bbs2-0003" title="AllanCL , EbmeierKP . The use of ECT and MST in treating depression. International Review of Psychiatry2011;23(5):400-12. [PMID: 22200130]">Allan 2011</a>) or non‐convulsive TMS (<a href="./references#CD012697-bbs2-0039" title="Holtzheimer PE 3rd, NemeroffCB . Advances in the treatment of depression. NeuroRx2006;3(1):42-56. [PMID: 16490412]">Holtzheimer 2006</a>) for schizophrenia and whether MST carries additional effects for people with schizophrenia. </p> <p>Pilot studies showed MST were safe for people with schizophrenia (<a href="./references#CD012697-bbs2-0043" title="JiangJ , LiQ , ShengJ , YangF , CaoX , ZhangT , et al. 25 Hz magnetic seizure therapy is feasible but not optimal for Chinese patients with schizophrenia: a case series. Frontiers in Psychiatry2018;9:224.">Jiang 2018</a>; <a href="./references#CD012697-bbs2-0088" title="Tang VM , Blumberger DM , McClintock SM , Kaster TS , Rajji TK , DownarJ , et al. Magnetic seizure therapy in treatment-resistant schizophrenia: a pilot study. Front Psychiatry2017;8:310.">Tang 2017</a>).  Also, as it may cause less cognition impairment, MST may be valuable in senior populations (<a href="./references#CD012697-bbs2-0061" title="LuberB , McClintockSM , LisanbySH . Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. Dialogues in Clinical Neuroscience2013;15(1):87-98. [PMID: 23576892]">Luber 2013</a>).  </p> <p>To our knowledge, to date there has been no systematic review of RCTs to address the safety and efficacy of MST for schizophrenia, which is important for guiding clinical practice and further development of this novel treatment. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012697-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012697-sec-0014"></div> <p>To evaluate the efficacy and tolerability of magnetic seizure therapy (MST) for people with schizophrenia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012697-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012697-sec-0015"></div> <section id="CD012697-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012697-sec-0017"> <h4 class="title">Types of studies</h4> <p>All relevant randomised controlled trials. If a trial was described as 'double‐blind' but implied randomisation, we would include such trials in a sensitivity analysis (see <a href="#CD012697-sec-0092">Sensitivity analysis</a>). We excluded quasi‐randomised studies, such as those allocating by alternate days of the week. Where people  were given additional treatments within MST, we would only include data if the adjunct treatment was evenly distributed between groups and it was only the MST that was randomised. There were no restrictions on language or publication status. </p> </section> <section id="CD012697-sec-0018"> <h4 class="title">Types of participants</h4> <p>Adults, however defined, with schizophrenia or related disorders, including schizophreniform disorder, schizoaffective disorder and delusional disorder, again, by any means of diagnosis. </p> <p>We were interested in making sure that information was as relevant to the current care of people with schizophrenia as possible, so we clearly highlighted the current clinical state (acute, early post‐acute, partial remission, remission) as well as the stage (prodromal, first episode, early illness, persistent) and whether the studies primarily focused on people with particular problems (for example, negative symptoms, treatment‐resistant illnesses). </p> <p>We excluded studies in which the psychotic symptoms were caused by definite physical conditions such as cerebral lesions, hyperthyroidism. </p> </section> <section id="CD012697-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD012697-sec-0020"> <h5 class="title">1. Experimental intervention</h5> <p>Magnetic seizure therapy, however defined, performed under general anaesthesia, inducing a seizure by electromagnetic fields (See <a href="#CD012697-sec-0009">Background</a>). </p> <p>The experimental intervention might be:</p> <p>1.1 Magnetic seizure therapy; or</p> <p>1.2 Magnetic seizure therapy + standard care.</p> </section> <section id="CD012697-sec-0021"> <h5 class="title">2. Comparator intervention</h5> <p>Comparators might be one or combination of:</p> <p>2.1 Placebo (sham MST) or waiting‐list or standard care;</p> <p>2.2 Antipsychotic medications;</p> <p>2.3 Electroconvulsive therapy;</p> <p>2.4 Other physical treatments (e.g. Tai Ji, acupuncture, etc); or</p> <p>2.5 Psychosocial therapies (e.g. cognitive behavioural therapy, psychoanalysis, art therapy, etc). </p> </section> </section> <section id="CD012697-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We divided outcomes into short term (less than 6 months), medium term (7 to 12 months) and long term (over 1 year). </p> <p>We reported binary outcomes recording clear and clinically meaningful degrees of change (e.g. global impression of much improved, or more than 50% improvement on a rating scale ‐ as defined within the trials) before any others. Thereafter, we would list other binary outcomes and then those that were continuous. </p> <section id="CD012697-sec-0023"> <h5 class="title">Primary outcomes</h5> <section id="CD012697-sec-0024"> <h6 class="title">1. Global state</h6> <p>1.1. Clinically important change ‐ as defined by individual studies (e.g. rated by any validated assessment such as the Clinical Global Impression Scale (CGI) (<a href="./references#CD012697-bbs2-0034" title="GuyW . Clinical Global Impression Scale. In: The ECDEU Assessment Manual for Psychopharmacology - Revised. Rockville, MD: National Institute of Mental Health, 1976:218-22.">Guy 1976</a>), the Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD012697-bbs2-0072" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799-812.">Overall 1962</a>), the Positive and Negative Syndrome Scale (PANSS) (<a href="./references#CD012697-bbs2-0046" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>)).(acute phase studies) </p> <p>1.2 Relapse ‐ as defined by individual studies. (studies that investigated the relapse prevention effect of a treatment in stable schizophrenia) </p> </section> <section id="CD012697-sec-0025"> <h6 class="title">2. Cognitive functioning</h6> <p>2.1 Clinically important change ‐ as defined by individual studies (e.g. rated by any validated assessment such as the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) (<a href="./references#CD012697-bbs2-0070" title="NuechterleinKH , GreenMF , KernRS , BaadeLE , BarchDM , CohenJD , et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. American Journal of Psychiatry2008;165(2):203-13. [PMID: 18172019]">Nuechterlein 2008</a>) </p> </section> <section id="CD012697-sec-0026"> <h6 class="title">3. Adverse effects</h6> <p>3.1 Clinically important adverse effects</p> </section> </section> <section id="CD012697-sec-0027"> <h5 class="title">Secondary outcomes</h5> <section id="CD012697-sec-0028"> <h6 class="title">1. Global state</h6> <p>1.1 Any change in global state, as defined by individual studies<br/>1.2 Average endpoint/change score global state scale </p> </section> <section id="CD012697-sec-0029"> <h6 class="title">2. Cognitive functioning</h6> <p>2.1 Any change in overall cognitive functioning, as defined by each study<br/>2.2 Average endpoint/change score in cognitive functioning rating scale </p> </section> <section id="CD012697-sec-0030"> <h6 class="title">3. Adverse effects</h6> <section id="CD012697-sec-0031"> <p><b>3.1 General adverse effects</b></p> <p>3.1.1 At least one adverse effect<br/>3.1.2 Average endpoint/change scores in adverse‐effect scales </p> </section> <section id="CD012697-sec-0032"> <p><b>3.2 Specific adverse effects</b></p> <p>3.2.1 Anticholinergic<br/>3.2.2 Cardiovascular<br/>3.2.3 Central nervous system<br/>3.2.4 Gastrointestinal<br/>3.2.5 Endocrine (e.g. amenorrhoea, galactorrhoea, hyperlipidaemia, hyperglycaemia, hyperinsulinaemia)<br/>3.2.6 Haematology (e.g. haemogram, leukopenia, agranulocytosis/neutropenia)<br/>3.2.7 Hepatic (e.g. abnormal transaminase, abnormal liver function)<br/>3.2.8 Metabolic<br/>3.2.9 Movement disorders<br/>3.2.10 Various other </p> </section> </section> <section id="CD012697-sec-0033"> <h6 class="title">4. Mental state</h6> <section id="CD012697-sec-0034"> <p><b>4.1 Overall</b></p> <p>4.1.1 Any change in overall mental state, as defined by each study<br/>4.1.2 Average endpoint/change score in total mental state scale </p> </section> <section id="CD012697-sec-0035"> <p><b>4.2 Positive symptoms</b></p> <p>4.2.1 Clinically important change in positive symptoms, as defined by each study<br/>4.2.2 Any change in positive symptoms, as defined by each study<br/>4.2.3 Average endpoint/change score in total positive mental state subscale </p> </section> <section id="CD012697-sec-0036"> <p><b>4.3 Negative symptoms</b></p> <p>4.3.1 Clinically important change in negative symptoms, as defined by each study<br/>4.3.2 Any change in negative symptoms, as defined by each study<br/>4.3.3 Average endpoint/change score in total negative mental state subscale </p> </section> <section id="CD012697-sec-0037"> <p><b>4.4 Aggressive symptoms/agitation</b></p> <p>4.4.1 Clinically important change in aggressive symptoms/agitation, as defined by each of the studies<br/>4.4.2 Any change in aggressive symptoms/agitation, as defined by each study<br/>4.4.3 Average endpoint/change score in aggressive symptoms/agitation scale </p> </section> <section id="CD012697-sec-0038"> <p><b>4.5 Depressive symptoms</b></p> <p>4.5.1 Clinically important change in depressive symptoms, as defined by each of the studies </p> <p>4.5.2 Any change in depressive symptoms, as defined by each study<br/>4.5.3 Average endpoint/change score in depressive symptoms scale </p> </section> <section id="CD012697-sec-0039"> <p><b>4.6 Anxiety symptoms</b></p> <p>4.6.1 Clinically important change in anxiety symptoms, as defined by each study<br/>4.6.2 Any change in anxiety symptoms, as defined by each study<br/>4.6.3 Average endpoint/change score in anxiety symptoms scale </p> </section> </section> <section id="CD012697-sec-0040"> <h6 class="title">5. Quality of life</h6> <p>5.1 Clinically important change in quality of life, as defined by each study<br/>5.2. Any change in quality of life, as defined by each study<br/>5.3 Average endpoint/change score in quality of life scale </p> </section> <section id="CD012697-sec-0041"> <h6 class="title">6. Satisfaction</h6> <p>6.1. Any change in quality of life (patient or carers), as defined by each study<br/>6.2 Average endpoint/change score in quality of life scale (patient or carers) </p> </section> <section id="CD012697-sec-0042"> <h6 class="title">7. Service use</h6> <p>7.1 Hospital admission<br/>7.2 Duration of hospital stay<br/>7.3 Readmission<br/>7.4 Contact with psychiatric services (binary or continuous measures) </p> </section> <section id="CD012697-sec-0043"> <h6 class="title">8. Social functioning</h6> <p>8.1 Clinically important change in social functioning, as defined by each study<br/>8.2 Any change in social functioning, as defined by each study<br/>8.3 Average endpoint/change score in social functioning scale<br/>8.4 Imprisonment (police contact and arrest)<br/>8.5 Employment status (employed/unemployed)<br/>8.6 Accommodation status<br/>8.7 Alcohol use<br/>8.8 Illicit drug use<br/>8.9 Occurrence of violent incidents (to self, others or property) </p> </section> <section id="CD012697-sec-0044"> <h6 class="title">9. Leaving the study early</h6> <p>9.1 Any reason<br/>9.2 Due to adverse effect<br/>9.3 Due to inefficacy </p> </section> <section id="CD012697-sec-0045"> <h6 class="title">10. Economic</h6> <p>10.1 Direct costs<br/>10.2 Indirect costs<br/>10.3 Cost‐effectiveness </p> </section> </section> </section> </section> <section id="CD012697-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012697-sec-0047"> <h4 class="title">Electronic searches</h4> <p>On 3 July 2017, 27 August 2019, 10 February 2021, and 06 March 2022, the information specialist searched the register using the following search strategy. </p> <p>(*Magnetic Seizure Therapy*) in Intervention Field of STUDY</p> <p>In such a study‐based register, searching on the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD012697-bbs2-0080" title="ShokranehF , AdamsCE . Study-based registers of randomized controlled trials: starting a systematic review with data extraction or meta-analysis. BioImpacts2017;7(4):209-17. [DOI: 10.15171/bi.2017.25]">Shokraneh 2017</a>). This allows rapid and accurate searches that reduce waste in the next steps of systematic reviewing (<a href="./references#CD012697-bbs2-0081" title="ShokranehF , AdamsCE . Study-based registers reduce waste in systematic reviewing: discussion and case report. Systematic Reviews2019;8:129. [DOI: 10.1186/s13643-019-1035-3]">Shokraneh 2019</a>). </p> <p>Following the methods from Cochrane (<a href="./references#CD012697-bbs2-0050" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , MetzendorfM , et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (eds). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated Feb 2021). Cochrane 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Lefebvre 2021</a>), the Information Specialist compiles this register from systematic searches of major resources and their monthly updates (unless otherwise specified). </p> <p> <ul id="CD012697-list-0001"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library</p> </li> <li> <p>MEDLINE</p> </li> <li> <p>Embase</p> </li> <li> <p>Allied and Complementary Medicine (AMED)</p> </li> <li> <p>BIOSIS</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL)</p> </li> <li> <p>PsycINFO</p> </li> <li> <p>PubMed</p> </li> <li> <p>US National Institute of Health Ongoing Trials Register (<a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>) </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="https://www.who.int/clinical-trials-registry-platform" target="_blank">www.who.int/ictrp</a>) </p> </li> <li> <p>ProQuest Dissertations and Theses A&amp;I and its quarterly update</p> </li> </ul> </p> <p>The register also includes handsearches and conference proceedings (see <a href="https://schizophrenia.cochrane.org/register-trials" target="_blank">Group's website</a>). It does not place any limitations on language, date, document type or publication status. </p> </section> <section id="CD012697-sec-0048"> <h4 class="title">Searching other resources</h4> <section id="CD012697-sec-0049"> <h5 class="title">1. Reference searching</h5> <p>We searched the references of relevant reviews and studies and inspected the reference lists. </p> </section> <section id="CD012697-sec-0050"> <h5 class="title">2. Personal contact</h5> <p>We contacted authors of the included study. We contacted experts of the field and manufacturers including Magstim in the UK and MagVenture A/S in Denmark for information regarding unpublished or ongoing trials. No additional eligible studies were identified.   </p> </section> </section> </section> <section id="CD012697-sec-0051"> <h3 class="title" id="CD012697-sec-0051">Data collection and analysis</h3> <section id="CD012697-sec-0052"> <h4 class="title">Selection of studies</h4> <p>Two review authors, HW and XC, independently examined the reports obtained from the searches. We planned to contact the authors of the eligible study/studies for clarification if it was not possible to resolve disagreement by discussion. </p> </section> <section id="CD012697-sec-0053"> <h4 class="title">Data extraction and management</h4> <section id="CD012697-sec-0054"> <h5 class="title">1. Extraction</h5> <p>Review authors HW and XC extracted data independently in duplicate. We planned to extract data presented only in graphs and figures whenever possible, but would have included these data only if two review authors independently had the same result. If studies were multicentre, where possible, we planned to extract data relevant to each. If necessary, we planned to contact authors through an open‐ended request in order to obtain missing information or for clarification. With any remaining problems, a third review author would have been involved to clarify issues and we would have documented these final decisions. </p> </section> <section id="CD012697-sec-0055"> <h5 class="title">2. Management</h5> <section id="CD012697-sec-0056"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto standard, simple forms.</p> </section> <section id="CD012697-sec-0057"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:<br/>a) the psychometric properties of the measuring instrument had been described in a peer‐reviewed journal (<a href="./references#CD012697-bbs2-0063" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249-52.">Marshall 2000</a>);<br/>b) the measuring instrument had not been written or modified by one of the trialists for that particular trial; and<br/>c) the instrument was a global assessment of an area of functioning and not subscores which are not, in themselves, validated or shown to be reliable. However, we would include subscores of scales if these were validated or if these were predefined in a scale such as the positive symptom, negative symptom and general symptom scores of the Positive and Negative Syndrome Scale (PANSS, <a href="./references#CD012697-bbs2-0046" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>). </p> <p>Ideally the measuring instrument should either be i. a self‐report or ii. completed by an independent rater or relative (not the therapist). We, however, realise that this is not often reported clearly. </p> </section> <section id="CD012697-sec-0058"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data can remove a component of between‐person variability from the analysis. On the other hand calculation of change needs two assessments (baseline and endpoint) which can be difficult in unstable and difficult‐to‐measure conditions such as schizophrenia. We have decided to primarily use endpoint data, and only use change data if the former are not available. If necessary, we would combine endpoint and change data in the analysis. This procedure is possible when using mean differences (MDs) (<a href="./references#CD012697-bbs2-0019" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook/archive/v6.1.">Deeks 2020</a>) and also when using standardised mean differences (SMDs). Although theoretically the combination of change and endpoint data when SMDs are used can be problematic, meta‐epidemiological research has shown that on average no major over‐ or underestimations can be expected (<a href="./references#CD012697-bbs2-0015" title="Da CostaBR , NüeschE , RutjesAW , JohnstonBC , ReichenbachS , TrelleS , et al. Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. Journal of Clinical Epidemiology2013;66(8):847-55. [DOI: 10.1016/j.jclinepi.2013.03.009]">Da Costa 2013</a>). </p> </section> <section id="CD012697-sec-0059"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we applied the following check to relevant continuous data before inclusion. </p> <p>For endpoint data from studies including fewer than 200 participants, we calculated the observed mean minus the lowest possible value of the scale and divided this by the standard deviation (<a href="./references#CD012697-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions. 6.1, updated September 2020 edition. John Wiley &amp; Son, 2020.">Higgins 2020</a>). </p> <p>For example, in a scale that has the possible lowest values higher than 0 (such as the Positive and Negative Syndrome Scale (PANSS), which can have values from 30 to 210 (<a href="./references#CD012697-bbs2-0046" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>)), we subtracted the minimum score (in this case, 30) from the observed mean, and then divided by the standard deviation. In a scale that has 0 as the minimum possible score, we divided the observed mean by the standard deviation. </p> <p>For this calculation, we checked the original publication of the scales referenced in the studies, in order to understand if they could have a lowest possible score different from 0, and the adjustment described above was needed or not. </p> <p>If this ratio obtained is lower than one, it strongly suggests that the data are skewed. If it is higher than one but less than two, there is a suggestion that the data are skewed; if the ratio is larger than two, it is less likely that they are skewed (<a href="./references#CD012697-bbs2-0004" title="AltmanDG , BlandJM . Detecting skewness from summary information. British Medical Journal1996;313(7066):1200.">Altman 1996</a>). </p> <p>Where there is suggestion of skewness (ratio &lt; than 2), we planned to exclude the relevant studies in a sensitivity analysis to check if they had an impact on the results (see <a href="#CD012697-sec-0092">Sensitivity analysis</a> for further details). </p> <p>Skewed results were nevertheless reported in Additional tables.</p> <p>We would have entered all relevant data from studies of more than 200 participants in the analysis irrespective of the above rules, because skewed data pose less of a problem in large studies. We would also enter all relevant change data as, when continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to tell whether data are skewed. </p> </section> <section id="CD012697-sec-0060"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials we intended, if necessary, to convert variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD012697-sec-0061"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we would make efforts to convert outcome measures to dichotomous data. This could be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that, if there is a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD012697-bbs2-0072" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799-812.">Overall 1962</a>) or the PANSS (<a href="./references#CD012697-bbs2-0046" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD012697-bbs2-0053" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?Schizophrenia Research2005;79(2-3):231-8. [PMID: 15982856]">Leucht 2005a</a>; <a href="./references#CD012697-bbs2-0054" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366-71. [PMID: 16199797]">Leucht 2005b</a>). If data based on these thresholds were not available, we would use the primary cut‐off presented by the original authors, because the exact cut‐off is not as important in a meta‐analysis using risk ratios or odds ratios as effect sizes (<a href="./references#CD012697-bbs2-0031" title="FurukawaTA , AkechiT , WagenpfeilS , LeuchtS . Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials. Schizophrenia Research2011;126(1-3):212-219. [DOI: 10.1016/j.schres.2010.10.016]">Furukawa 2010</a>). </p> </section> <section id="CD012697-sec-0062"> <h6 class="title">2.7 Direction of effect in graphs</h6> <p>We planned to report the direction of effect in graphs.</p> </section> </section> </section> <section id="CD012697-sec-0063"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Again, review authors HW and XC worked independently to assess risk of bias by using criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012697-bbs2-0037" title="HigginsJPT , AltmanDG , SterneJAC , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011b</a>), risk of bias tool 1. This set of criteria is based on evidence of associations between overestimate of effect and high risk of bias in domains such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting.  </p> <p>We agreed on the final assessments of risk of bias of the included study and noted the level of risk of bias in the text of the review, the Summary of findings table and figures. </p> </section> <section id="CD012697-sec-0064"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012697-sec-0065"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RRs are more intuitive (<a href="./references#CD012697-bbs2-0008" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405-11. [PMID: 10667106]">Boissel 1999</a>) than odds ratios and that odds ratios tend to be interpreted as RRs by clinicians (<a href="./references#CD012697-bbs2-0017" title="DeeksJ . Issues in the selection for meta-analyses of binary data. In: 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.">Deeks 2000</a>). The number needed to treat for an additional beneficial/harmful outcome (NNTB/NNTH) statistic with its CIs is intuitively attractive to clinicians but is problematic both in its accurate calculation in meta‐analyses and interpretation (<a href="./references#CD012697-bbs2-0042" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27-30. [PMID: 19438480]">Hutton 2009</a>). For binary data presented in the <a href="./full#CD012697-tbl-0001">summary of findings Table 1</a>, where possible, we calculated illustrative comparative risks. </p> </section> <section id="CD012697-sec-0066"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we estimated the MD between groups. We preferred not to calculate standardised effect size measures (SMD). However, if scales were different yet of considerable similarity, we would presume there was a small difference in measurement, and we would calculate the SMD. It should be noted that the SMD can be transformed to the MD by using the formula MD = SMD x Standard Deviation of the scale of interest (<a href="./references#CD012697-bbs2-0038" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions. 6.1, updated September 2020 edition. John Wiley &amp; Son, 2020.">Higgins 2020</a>). </p> </section> </section> <section id="CD012697-sec-0067"> <h4 class="title">Unit of analysis issues</h4> <section id="CD012697-sec-0068"> <h5 class="title">1. Cluster trials</h5> <p>Analysis and pooling of data from cluster trials poses problems. Firstly, authors often fail to account for intraclass correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD012697-bbs2-0022" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623-9.">Divine 1992</a>) whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD012697-bbs2-0007" title="BlandJM . Statistics notes. Trials randomised in clusters. British Medical Journal1997;315:600.">Bland 1997</a>; <a href="./references#CD012697-bbs2-0033" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876-83.">Gulliford 1999</a>). </p> <p>Where clustering had been incorporated into the analysis of primary studies, we would have presented these data as if from a non‐cluster‐randomised study, but adjust for the clustering effect. </p> <p>Where clustering was not accounted for in primary studies, we would have presented data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. We would have sought to contact first authors of studies to obtain intra‐class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD012697-bbs2-0033" title="GullifordMC . Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876-83.">Gulliford 1999</a>). </p> <p>We had been advised that the binary data, as presented in a report, should be divided by a 'design effect'. This was calculated using the mean number of participants per cluster (m) and the ICC [Design effect = 1 + (m ‐ 1) * ICC] (<a href="./references#CD012697-bbs2-0023" title="DonnerA , KlarN . Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21:2971-80.">Donner 2002</a>). If the ICC was not reported, we would have assumed it to be 0.1 (<a href="./references#CD012697-bbs2-0090" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment1999;3(5):1-75.">Ukoumunne 1999</a>). </p> <p>If cluster studies had been appropriately analysed taking into account ICCs and relevant data documented in the report by study authors, synthesis with other studies would have been possible using the generic inverse variance technique. </p> </section> <section id="CD012697-sec-0069"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. This occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD012697-bbs2-0028" title="ElbourneD , AltmanDG , HigginsJPT , CurtinaF , WorthingtondHV , VaileA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9.">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we would have only used data of the first phase of cross‐over studies. </p> </section> <section id="CD012697-sec-0070"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involves more than two treatment arms, if relevant, we would have presented the additional treatment arms in comparisons. If data were binary we would have simply added these and combined them within the two‐by‐two table. If data were continuous, we would have combined data following the formula in section 7.7.3.8 (Combining groups) of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012697-bbs2-0036" title="HigginsJPT , GreenS , editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011a</a>). Where the additional treatment arms were not relevant, we would have not reproduced these data. We would list all treatment arms in the <a href="./references#CD012697-sec-0171" title="">Characteristics of included studies</a> table, even if they were not used in the review. </p> </section> </section> <section id="CD012697-sec-0071"> <h4 class="title">Dealing with missing data</h4> <section id="CD012697-sec-0072"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, data must lose credibility (<a href="./references#CD012697-bbs2-0094" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El-SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254-7.">Xia 2009</a>). If, for any particular outcome, more than 50% of data were unaccounted for, we would have not reproduced these data or used them within analyses. If, however, more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, we would have addressed this within the <a href="./full#CD012697-tbl-0001">summary of findings Table 1</a> by down‐rating quality. Finally, we would also have downgraded quality within the <a href="./full#CD012697-tbl-0001">summary of findings Table 1</a> should loss have been 25% to 50% in total. </p> </section> <section id="CD012697-sec-0073"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome was between 0% and 50% and where these data were not clearly described, we would have presented data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat (ITT) analysis). Those leaving the study early would be all assumed to have the same rates of negative outcome as those who completed. We would have used the rate of those who stayed in the study ‐ in that particular arm of the trial ‐ and applied this also to those who did not. We would have undertaken a sensitivity analysis testing how prone the primary outcomes were to change when data only from people who completed the study to that point were compared to the ITT analysis using the above assumptions. </p> </section> <section id="CD012697-sec-0074"> <h5 class="title">3. Continuous</h5> <section id="CD012697-sec-0075"> <h6 class="title">3.1 Attrition</h6> <p>We would have reproduced and used data where attrition for a continuous outcome was between 0% and 50%, and data only from people who completed the study to that point would have been reported. </p> </section> <section id="CD012697-sec-0076"> <h6 class="title">3.2 Standard deviations (SDs)</h6> <p>If SDs were not reported, we would have first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and CIs available for group means, and either P value or t value available for differences in mean, we would have calculated them according to the rules described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012697-bbs2-0036" title="HigginsJPT , GreenS , editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011a</a>): when only the SE is reported, SDs are calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012697-bbs2-0036" title="HigginsJPT , GreenS , editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011a</a>) present detailed formulae for estimating SDs from P values, t or F values, CIs, ranges or other statistics. If these formulae did not apply, we would have calculated the SDs according to a validated imputation method which was based on the SDs of the other included studies (<a href="./references#CD012697-bbs2-0030" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(7):7-10.">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study’s outcome and thus to lose information. We nevertheless would have examined the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD012697-sec-0077"> <h6 class="title">3.3 Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers, others use the method of last‐observation‐carried‐forward (LOCF), while more recently, methods such as multiple imputation or mixed effects models for repeated measurements (MMRM) have become more of a standard. While the latter methods seem somewhat better than LOCF (<a href="./references#CD012697-bbs2-0052" title="LeonAC , MallinckrodtCH , Chuang-SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001-5. [PMID: 16905632]">Leon 2006</a>), we feel that the high percentage of participants leaving the studies early and differences in the reasons for leaving the studies early between groups is often the core problem in randomised schizophrenia trials. Therefore, we do not exclude studies based on the statistical approach used. However, we would have preferably used the more sophisticated approaches, e.g. we would prefer MMRM or multiple imputation to LOCF and we would have only presented completer analyses if some kind of ITT data were not available at all. Moreover, we planned to address this issue in the item 'incomplete outcome data' of the Risk of bias tool. </p> </section> </section> </section> <section id="CD012697-sec-0078"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD012697-sec-0079"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We would have considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We would have simply inspected all studies for clearly outlying people or situations which we had not predicted would arise and discussed such situations or participant groups. </p> </section> <section id="CD012697-sec-0080"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We would have considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We would have simply inspected all studies for clearly outlying methods which we had not predicted would arise and discussed any such methodological outliers. </p> </section> <section id="CD012697-sec-0081"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD012697-sec-0082"> <h6 class="title">3.1 Visual inspection</h6> <p>We would have visually inspected graphs to investigate the possibility of statistical heterogeneity. </p> </section> <section id="CD012697-sec-0083"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>We would have investigated heterogeneity between studies by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD012697-bbs2-0035" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. British Medical Journal2003;327:557-60.">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on: i. magnitude and direction of effects, and ii. strength of evidence for heterogeneity (e.g. P value from Chi<sup>2</sup> test, or a CI for I<sup>2</sup>). We would have interpreted an I<sup>2</sup> estimate greater than or equal to around 50%, accompanied by a statistically significant Chi<sup>2</sup> statistic, as evidence of substantial levels of heterogeneity (section 9.5.2 <i>Cochrane Handbook for Systematic Reviews of Interventions)</i> (<a href="./references#CD012697-bbs2-0018" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Deeks 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we would have explored reasons for heterogeneity (<a href="#CD012697-sec-0088">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD012697-sec-0084"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD012697-bbs2-0026" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. British Medical Journal1997;315:629-34.">Egger 1997</a>). These were described in section 10.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012697-bbs2-0085" title="SterneJAC , EggerM , MoherD , editor(s). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Sterne 2011</a>). </p> <section id="CD012697-sec-0085"> <h5 class="title">1. Protocol versus full study</h5> <p>We would have compared outcomes in the protocol and in the published report. If the protocol was not available, we would have compared outcomes listed in the methods section of the trial report with actual reported results. </p> </section> <section id="CD012697-sec-0086"> <h5 class="title">2. Funnel plot</h5> <p>We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We only use funnel plots for outcomes where there are at least ten studies or more.  </p> </section> </section> <section id="CD012697-sec-0087"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model. It puts added weight onto small studies which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. We used fixed‐effect models for all analyses. </p> </section> <section id="CD012697-sec-0088"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD012697-sec-0089"> <h5 class="title">1. Subgroup analyses</h5> <section id="CD012697-sec-0090"> <h6 class="title">1.1 Primary outcomes</h6> <p>We planned to perform subgroup analyses on dose or frequency of MST, type and shape of coils, and placement of coils if enough data were gathered. </p> </section> </section> <section id="CD012697-sec-0091"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>We would have reported heterogeneity if inconsistency was high. First, we would have investigated whether data had been entered correctly. Second, if data were correct, we would visually inspect the graph and we would successively remove studies outside the company of the rest to see if homogeneity was restored. For this review, we had decided that, should this occur with data contributing to the summary finding of no more than around 10% of the total weighting, we would have presented data. If not, we would not pool these data and would discuss any issues. We know of no supporting research for this 10% cut‐off but are investigating use of prediction intervals as an alternative to this unsatisfactory state. </p> <p>When unanticipated clinical or methodological heterogeneity were obvious, we would have simply stated hypotheses regarding these for future reviews or versions of this review. We do not anticipate undertaking analyses relating to these. </p> </section> </section> <section id="CD012697-sec-0092"> <h4 class="title">Sensitivity analysis</h4> <p>If there were substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed below, we would not add data from the lower‐quality studies to the results of the higher‐quality trials, but would present these data within a subcategory. If their inclusion did not result in a substantive difference, they would remain in the analyses. </p> <section id="CD012697-sec-0093"> <h5 class="title">1. Implication of randomisation</h5> <p>If trials were described in some way as to imply randomisation, for the primary outcomes, we would pool data from the implied trials with trials that were clearly randomised. </p> </section> <section id="CD012697-sec-0094"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD012697-sec-0071">Dealing with missing data</a>), we would have compared the findings of the primary outcomes when we used our assumption compared with completer data only. If there was a substantial difference, we would report results and discuss them but continue to employ our assumption. </p> </section> <section id="CD012697-sec-0095"> <h5 class="title">3. Risk of bias</h5> <p>We would have analysed the effects of excluding trials that were at high risk of bias across one or more of the domains (see <a href="#CD012697-sec-0063">Assessment of risk of bias in included studies</a>) for the meta‐analysis of the primary outcome. </p> </section> <section id="CD012697-sec-0096"> <h5 class="title">4. Imputed values</h5> <p>We would have also undertaken a sensitivity analysis to assess the effects of including data from trials where we used imputed values for ICC in calculating the design effect in cluster‐randomised trials. </p> <p>Where imputation were made regarding missing SDs (see <a href="#CD012697-sec-0071">Dealing with missing data</a>), we would undertake a sensitivity analysis testing how prone results were to change when 'completer' data only were compared to the imputed data. If there was a substantial difference, we would report results and discuss them but continue to employ our imputation. </p> </section> <section id="CD012697-sec-0097"> <h5 class="title">5. Fixed‐effect and random‐effects models</h5> <p>We would have also synthesised data for the primary outcome using a random‐effects model to evaluate whether this altered the significance of the results, when compared with the use of a fixed‐effect model. </p> </section> </section> <section id="CD012697-sec-0098"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach to interpret findings (<a href="./references#CD012697-bbs2-0079" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schünemann 2020</a>) and exported data from our review using <a href="http://methods.cochrane.org/gradeing/gradepro-gdt" target="_blank">GRADEpro</a> to create the <a href="./full#CD012697-tbl-0001">summary of findings Table 1</a>. Summary of findings tables provide outcome‐specific information concerning the overall certainty of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes that we rated as important to patient care and decision‐making. We selected the following main outcomes for inclusion in the <a href="./full#CD012697-tbl-0001">summary of findings Table 1</a> (these outcomes were assessed at the study endpoint). </p> <p> <ul id="CD012697-list-0002"> <li> <p>Global state: clinically important change, as defined by individual studies (acute‐phase studies); </p> </li> <li> <p>Global state: relapse (relapse‐prevention studies);</p> </li> <li> <p>Cognitive functioning: clinically important change, as defined by individual studies;</p> </li> <li> <p>Adverse effects: clinically important adverse effects;</p> </li> <li> <p>Quality of life: clinically important change, as defined by individual studies;</p> </li> <li> <p>Social functioning: clinically important change in social functioning, as defined by each study; </p> </li> <li> <p>Leaving the study early: for any reason.</p> </li> </ul> </p> <p>If data were not available for these prespecified outcomes but were available for ones that were similar, we would present the closest outcome to the prespecified one in the table but take this into account when grading the finding. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012697-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012697-sec-0099"></div> <section id="CD012697-sec-0100"> <h3 class="title">Description of studies</h3> <p>For detailed description of studies, see <a href="./references#CD012697-sec-0171" title="">Characteristics of included studies</a> and <a href="./references#CD012697-sec-0172" title="">Characteristics of ongoing studies</a> tables.  </p> <section id="CD012697-sec-0101"> <h4 class="title">Results of the search</h4> <p>The Information Specialist searched the Cochrane Schizophrenia Group register of trials and retrieved two studies (3 reports). We included one study (2 reports) in our review and one ongoing study. There were no studies awaiting classification. </p> <p>See also <a href="#CD012697-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD012697-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD012697-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD012697-sec-0102"> <h4 class="title">Included studies</h4> <p>We identified one eligible study (<a href="./references#CD012697-bbs2-0001" title="JiangJ , LiJ , XuY , ZhangB , ShengJ , LiuD , et al. Magnetic seizure therapy compared to electroconvulsive therapy for schizophrenia: a randomized controlled trial. Front Psychiatry2021;12:770647. LiJ , ZhangX , JiangJ , ZhangB , TangY , ZhangT , et al. Comparison of electroconvulsive therapy and magnetic seizure therapy in schizophrenia: Structural changes/neuroplasticity. Psychiatry Research2022;312:114523. NCT02746965. Magnetic seizure therapy for schizophrenia. clinicaltrials.gov/show/NCT02746965 (first received 2017). ">Jiang 2021</a>). See also <a href="./references#CD012697-sec-0171" title="">Characteristics of included studies</a>. </p> <section id="CD012697-sec-0103"> <h5 class="title">1. Design and duration</h5> <p>The included study was a four‐week double‐blind RCT.</p> </section> <section id="CD012697-sec-0104"> <h5 class="title">2. Participants</h5> <p>Participants had a diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5). The mean age of participants in the MST group was 31 years and 34 years in the ECT group. Twenty‐four of 43 and 22 of 36 were females in the MST and the ECT group, respectively. Nineteen of them were clozapine‐resistant. All completers were on atypical antipsychotics. The participants were acutely ill. The baseline mean total PANSS score was 92.3 (SD 13.0) in the MST group and 99.1 (SD 11.6) in the ECT group. </p> </section> <section id="CD012697-sec-0105"> <h5 class="title">3. Size</h5> <p>Ninety‐three participants were assessed for eligibility and 79 were included.</p> </section> <section id="CD012697-sec-0106"> <h5 class="title">4. Setting</h5> <p>All participants were inpatients in settings in China.</p> </section> <section id="CD012697-sec-0107"> <h5 class="title">5. Interventions</h5> <p>The study compared MST plus standard care to ECT plus standard care. Session schedules were kept the same for both interventions and consisted of ten sessions, three sessions per week for the first fortnight and two for the second fortnight. Participants were under general anaesthesia with intravenous etomidate and propofol. Intravenous succinylcholine was used as a muscle relaxant and intravenous atropine was used to reduce airway secretions. Standard care was defined as participants continuing their usual antipsychotic medication treatments. </p> <section id="CD012697-sec-0108"> <h6 class="title">5.1 Magnetic seizure therapy</h6> <p>MST was administered at 50 Hz and 100% output. The pulse width was 370 µs, and the peak intensity of the magnetic field was 4.2 Tesla. The duration was titrated for each participant according to the induced seizure quality. The maximum duration was 20 seconds. When no seizures were generated, an extra stimulation lasting for 20 seconds was administered immediately. Magnetic stimulation was delivered via a twin coil with its midline on the vertex.  </p> </section> <section id="CD012697-sec-0109"> <h6 class="title">5.2 Electroconvulsive therapy</h6> <p>Bitemporal ECT was administered. The pulse width of the electrical stimulus was set to 0.5 ms. The energy used was tailored to each participant according to their age and the induced seizure quality. The maximum dosage was 100%. If no seizures were induced, the maximum dosage was administered immediately. </p> </section> </section> <section id="CD012697-sec-0110"> <h5 class="title">6. Outcomes</h5> <section id="CD012697-sec-0111"> <h6 class="title">6.1 General</h6> <p>The study provided data for the following primary outcomes and secondary outcomes: </p> <p> <ul id="CD012697-list-0003"> <li> <p>Global state: clinically important change ‐ number of participants with a clinical response. A clinical response was defined as a ≥ 25% reduction in the PANSS total score from baseline to the endpoint (improvement); </p> </li> <li> <p>Adverse effects: clinically important adverse effects ‐ number of participants with a delayed memory deficit. A delayed memory deficit was defined as a ≥ 10% decrease in the RBANS delayed memory score from baseline to the endpoint; </p> </li> <li> <p>Cognitive functioning: any change ‐ number of participants with improvement. An improvement was defined as any increase of RBANS total index from baseline to the endpoint; </p> </li> <li> <p>Cognitive functioning: change scores of RBANS total index from baseline to the endpoint;</p> </li> <li> <p>Mental state (overall): change scores of PANSS total score from baseline to the endpoint;</p> </li> <li> <p>Mental state (positive symptoms): change scores of PANSS positive subscale from baseline to the endpoint; </p> </li> <li> <p>Mental state (negative symptoms): change scores of PANSS negative subscale from baseline to the endpoint; </p> </li> <li> <p>Leaving the study early: any reason; due to adverse effect; due to inefficacy.</p> </li> </ul> </p> </section> <section id="CD012697-sec-0112"> <h6 class="title">6.2 Outcome scales providing useable data</h6> <p>Clinically important change was measured by the Positive and Negative Syndrome Scale (PANSS) (<a href="./references#CD012697-bbs2-0046" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.">Kay 1986</a>). PANSS is a clinician‐rated scale that contains 30 items. Three subscales, positive scale (7 items), negative scale (7 items) and general psychopathology scale (16 items) are rated on a seven‐point Likert scale (1 to 7). Higher scores indicate worse performance. The PANSS total score is the sum of three subscales, ranging from 30 to 210. </p> <p>Cognitive functioning was measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (<a href="./references#CD012697-bbs2-0075" title="RandolphC , TierneyMC , MohrE , ChaseTN . The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology1998;20(3):310-9.">Randolph 1998</a>). RBANS generates 12 subtests which form five index scores (immediate memory, visuospatial/constructional, language, attention and delayed memory) and a total scale index score (range from 40 to 160) (<a href="./references#CD012697-bbs2-0045" title="KarantzoulisS , NovitskiJ , GoldM , RandolphC . The repeatable battery for the assessment of neuropsychological status (RBANS): utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Archives of Clinical Neuropsychology2013;28(8):837-44.">Karantzoulis 2013</a>). The scores are age‐adjusted. Higher scores indicate better cognitive functioning. </p> </section> </section> <section id="CD012697-sec-0113"> <h5 class="title">7. Funding</h5> <p>The study was not funded by industrial companies but by public institutions.</p> </section> </section> <section id="CD012697-sec-0114"> <h4 class="title">Excluded studies</h4> <p>We did not exclude any studies from the search.</p> <section id="CD012697-sec-0115"> <h5 class="title">Ongoing studies</h5> <p>We identified one ongoing study (<a href="./references#CD012697-bbs2-0002" title="NCT02926976. The optimal treatment for treatment-resistant schizophrenia. ClinicalTrials.gov/show/NCT02926976 (first received 2017). ">NCT02926976</a>). See also <a href="./references#CD012697-sec-0172" title="">Characteristics of ongoing studies</a>. </p> </section> <section id="CD012697-sec-0116"> <h5 class="title">Awaiting assessment</h5> <p>There was no study awaiting assessment. </p> </section> </section> </section> <section id="CD012697-sec-0117"> <h3 class="title">Risk of bias in included studies</h3> <p>See also <a href="#CD012697-fig-0002">Figure 2</a>, <a href="#CD012697-fig-0003">Figure 3</a> and <a href="./references#CD012697-sec-0171" title="">Characteristics of included studies</a> </p> <div class="figure" id="CD012697-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012697-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012697-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012697-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012697-sec-0118"> <h4 class="title">Allocation</h4> <p>The study used a computer‐generated random sequence by an independent biostatistician, and the numbers were concealed in opaque envelopes; therefore, we considered the selection bias to be of low risk. </p> </section> <section id="CD012697-sec-0119"> <h4 class="title">Blinding</h4> <p>The authors of the study made efforts to blind the participants by identical procedures and room settings prior to treatments. However, due to the nature of the interventions, the treating clinicians were not blinded from the first session. As a result, we considered the risk of performance bias to be unclear. </p> <p>The outcomes were rated by independent assessors who were blinded to the interventions. We rated the risk of detection bias to be low. </p> </section> <section id="CD012697-sec-0120"> <h4 class="title">Incomplete outcome data</h4> <p>Ten per cent (8 in 79 participants) dropped out of the study. Authors of the study conducted intention‐to‐treat (ITT) analysis and used 'the worst‐case scenario' to impute missing data. Reasons for dropouts were reported. We considered the risk of attrition bias to be low. </p> </section> <section id="CD012697-sec-0121"> <h4 class="title">Selective reporting</h4> <p>There was no protocol for the study. Outcomes listed in the trial register (<a href="https://www.clinicaltrials.gov/ct2/show/study/NCT02746965" target="_blank">www.clinicaltrials.gov/ct2/show/study/NCT02746965</a>) were reported. However, data at multiple time points were planned. Due to early termination of the study, only data at four weeks were reported. We rated the risk of reporting bias to be high. </p> </section> <section id="CD012697-sec-0122"> <h4 class="title">Other potential sources of bias</h4> <p>The study was terminated early due to coil malfunction and there was baseline imbalance between two groups. Participants in the ECT group had more severe symptoms than participants in the MST group. As a result, we rated the risk of other bias as high. </p> </section> </section> <section id="CD012697-sec-0123"> <h3 class="title" id="CD012697-sec-0123">Effects of interventions</h3> <p>See: <a href="./full#CD012697-tbl-0001"><b>Summary of findings 1</b> Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</a> </p> <p>Only one study (n = 79) was included in this review. It was short term (4 weeks study duration) and examined adults with schizophrenia. </p> <section id="CD012697-sec-0124"> <h4 class="title">MST plus standard care verus ECT plus standard care</h4> <section id="CD012697-sec-0125"> <h5 class="title">Primary outcomes</h5> <section id="CD012697-sec-0126"> <h6 class="title">1. Global state: clinically important change</h6> <section id="CD012697-sec-0127"> <p><b>1.1 Number of participants with clinical response </b></p> <p>A clinical response was defined as a ≥ 25% reduction from baseline to the endpoint of the PANSS total score. </p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, RR 1.12, 95% CI 0.73 to 1.70, <a href="./references#CD012697-fig-0004" title="">Analysis 1.1</a>).  </p> </section> </section> <section id="CD012697-sec-0128"> <h6 class="title">2. Cognitive functioning: clinically important change</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0129"> <h6 class="title">3. Adverse effects: clinically important adverse effects</h6> <section id="CD012697-sec-0130"> <p><b>3.1 Number of participants with a delayed memory deficit</b></p> <p>A delayed memory deficit was defined as a ≥ 10% decrease from baseline to the endpoint of the RBANS delayed memory score. </p> <p>We found very low certainty of evidence that there was a favourable effect for MST compared to ECT (n = 79, RR 0.63, 95% CI 0.41 to 0.96, <a href="./references#CD012697-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> </section> <section id="CD012697-sec-0131"> <h5 class="title">Secondary outcomes</h5> <section id="CD012697-sec-0132"> <h6 class="title">1. Global state: any change in global state or average endpoint/change score of global state scale </h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0133"> <h6 class="title">2. Cognitive functioning</h6> <section id="CD012697-sec-0134"> <p><b>2.1 Any change of overall cognitive functioning: number of participants with improvement.</b></p> <p>An improvement was defined as any increase of RBANS total index from baseline to the endpoint. </p> <p>We found very low certainty of evidence that there was a favourable effect for MST compared to ECT (n = 47, RR 3.30, 95% CI 1.29 to 8.47, <a href="./references#CD012697-fig-0006" title="">Analysis 1.3</a>).  </p> </section> <section id="CD012697-sec-0135"> <p><b>2.2 Average change score from baseline to endpoint of RBANS total index (high = good)</b></p> <p>We found very low certainty of evidence that there was a favourable effect for MST compared to ECT (n = 79, MD 5.80, 95% CI 0.80 to 10.80, <a href="./references#CD012697-fig-0007" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD012697-sec-0136"> <h6 class="title">3. Adverse effects</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0137"> <h6 class="title">4. Mental state</h6> <section id="CD012697-sec-0138"> <p><b>4.1 Overall: average change score from baseline to endpoint of PANSS total (high = poor)</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, MD ‐0.20, 95% CI ‐8.08 to 7.68, <a href="./references#CD012697-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD012697-sec-0139"> <p><b>4.2 Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor)</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, MD 1.40, 95% CI ‐1.97 to 4.77, <a href="./references#CD012697-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD012697-sec-0140"> <p><b>4.3 Negative symptoms: average change score from baseline to endpoint of PANSS negative subscale (high = poor)</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, MD ‐1.00, 95% CI ‐3.85 to 1.85, <a href="./references#CD012697-fig-0010" title="">Analysis 1.7</a>). </p> </section> </section> <section id="CD012697-sec-0141"> <h6 class="title">5. Quality of life</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0142"> <h6 class="title">6. Satisfaction</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0143"> <h6 class="title">7. Service use</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0144"> <h6 class="title">8. Social functioning</h6> <p>No data were available.</p> </section> <section id="CD012697-sec-0145"> <h6 class="title">9. Leaving the study early</h6> <section id="CD012697-sec-0146"> <p><b>9.1 Any reason</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, RR 2.51, 95% CI 0.73 to 8.59, <a href="./references#CD012697-fig-0011" title="">Analysis 1.8</a>). </p> </section> <section id="CD012697-sec-0147"> <p><b>9.2 Due to adverse effect</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, RR 3.35, 95% CI 0.39 to 28.64, <a href="./references#CD012697-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD012697-sec-0148"> <p><b>9.3 Due to inefficacy</b></p> <p>We found very low certainty of evidence that there was no difference between groups (n = 79, RR 2.52, 95% CI 0.11 to 60.10, <a href="./references#CD012697-fig-0013" title="">Analysis 1.10</a>). </p> </section> </section> <section id="CD012697-sec-0149"> <h6 class="title">10. Economic</h6> <p>No data were available.</p> </section> </section> <section id="CD012697-sec-0150"> <h5 class="title">Subgroup analysis</h5> <p>There were not enough data for the prespecified subgroups.</p> </section> <section id="CD012697-sec-0151"> <h5 class="title">Sensitivity analysis</h5> <p>Prespecified sensitivity analyses were not conducted as there were insufficient data.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012697-sec-0152" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012697-sec-0152"></div> <section id="CD012697-sec-0153"> <h3 class="title" id="CD012697-sec-0153">Summary of main results</h3> <p>We included only one short‐term study with 79 participants which compared MST plus standard care with ECT plus standard care. Data were very limited. The overall risk of bias of the study was high. We rated the following domains as having low risk of bias: random sequence generation, allocation concealment, blinding of outcome assessment, and incomplete outcome data; unclear risk of bias in the domain, blinding of participants and personnel; and high risk of bias in the domains selective reporting and other bias (baseline imbalance and early termination due to technical problems of the MST machine). </p> <p>We found that MST and ECT may be comparable in improving the global state of adults with schizophrenia, and in improving overall, positive and negative symptoms. We found that MST may cause less delayed memory deficit and less cognitive deterioration and improve cognitive function compared to ECT. There may be no difference between the two groups in terms of leaving the study early due to any reason, adverse effect, or inefficacy.  </p> <p>Since all the findings were based on very low certainty of evidence, we were not sure these comparable or favourable effects of MST over ECT were its true effects.  </p> </section> <section id="CD012697-sec-0154"> <h3 class="title" id="CD012697-sec-0154">Overall completeness and applicability of evidence</h3> <p>There were too few data to address the review question. The very limited data were only about adults with acute schizophrenia in a short‐term setting. There were no data on median and long‐term effects of MST and no information about subgroups, such as first‐episode schizophrenia, or vulnerable populations (elderly, children). From the available evidence, cognitive function and adverse effects were not adequately assessed and there were no data about quality of life, satisfaction, service use, social functioning and economic outcomes. </p> <p>Current findings are at most preliminary and cannot be applied directly to clinical practice. RCTs are warranted to investigate the effect of the novel intervention MST for people with schizophrenia. </p> </section> <section id="CD012697-sec-0155"> <h3 class="title" id="CD012697-sec-0155">Quality of the evidence</h3> <p>Results for three outcomes in the SoF table were available, i.e. clinically important change in global state; clinically important change in cognitive functioning; and leaving the study early due to any reason. We downgraded the certainty of the evidence by two levels for high RoB and by one to two levels for imprecision because of small sample size and the CIs including appreciable benefit and harm. We assessed the overall certainty of the evidence to be very low for all outcomes using GRADE. </p> </section> <section id="CD012697-sec-0156"> <h3 class="title" id="CD012697-sec-0156">Potential biases in the review process</h3> <p>We have used the Cochrane Schizophrenia Group's study‐based trial register to identify eligible studies. We also contacted experts in the fields and manufacture companies to look for additional unpublished studies or data. However, we retrieved very limited RCT data relevant to this review. We restricted the inclusion criteria to RCTs to ensure quality of the evidence and avoid risk of bias, so data from other types of studies, such as non‐randomised or observational studies were not assessed and summarised in this review. </p> <p>Three study authors, including the lead author and the principal investigator of the included study were co‐authors of the current review. We have taken measures to prevent bias by excluding them from screening and selection of studies, data extraction and assessment of risk of bias and the quality of the evidence.  </p> </section> <section id="CD012697-sec-0157"> <h3 class="title" id="CD012697-sec-0157">Agreements and disagreements with other studies or reviews</h3> <p>One systematic review (<a href="./references#CD012697-bbs2-0096" title="ZhangXY , ChenHD , LiangWN , YangXH , CaiDB , HuangX , et al. Adjunctive magnetic seizure therapy for schizophrenia: a systematic review. Frontiers in Psychiatry2021;12:813590.">Zhang 2021</a>) synthesised two single‐armed self‐controlled studies and found low certainty of evidence that MST improved psychotic symptoms but with a high discontinuation rate. It also reported inconsistent evidence regarding cognitive adverse effects of MST. The review resonated with our findings that currently there was a lack of high‐quality evidence investigating the effect of MST for people with schizophrenia. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012697-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD012697-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012697-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012697-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 1: Global state: clinically important change  ‐ number of participants with clinical response" data-id="CD012697-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 1: Global state: clinically important change  ‐ number of participants with clinical response </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 2: Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit" data-id="CD012697-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 2: Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 3: Cognitive functioning: any change ‐ number of participants with improvement" data-id="CD012697-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 3: Cognitive functioning: any change ‐ number of participants with improvement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 4: Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good)" data-id="CD012697-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 4: Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 5: Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor)" data-id="CD012697-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 5: Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 6: Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor)" data-id="CD012697-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 6: Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 7: Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor)" data-id="CD012697-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 7: Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 8: Leaving the study early: any reason" data-id="CD012697-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 8: Leaving the study early: any reason </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 9: Leaving the study early: due to adverse effect" data-id="CD012697-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 9: Leaving the study early: due to adverse effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012697-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/urn:x-wiley:14651858:media:CD012697:CD012697-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 10: Leaving the study early: due to inefficacy" data-id="CD012697-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_t/tCD012697-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care, Outcome 10: Leaving the study early: due to inefficacy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/media/CDSR/CD012697/image_n/nCD012697-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012697-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute schizophrenia<br/><b>Setting:</b> inpatient<br/><b>Intervention:</b> magnetic seizure therapy + standard care<br/><b>Comparison:</b> electroconvulsive therapy + standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with electroconvulsive therapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with magnetic seizure therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: clinically important change <br/>assessed by: number of participants with a clinical response<br/>Study duration: 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.12<br/>(0.73 to 1.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>A clinical response was defined as a ≥ 25% reduction from baseline to the endpoint of the PANSS total score. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>472 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000<br/>(345 to 803) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive functioning: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effects: clinically important adverse effects<br/>assessed by: number of participants with a delayed memory deficit<br/>Study duration: 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.41 to 0.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>A delayed memory deficit was defined as a ≥ 10% decrease from baseline to the endpoint of the RBANS delayed memory score. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>667 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>420 per 1000<br/>(273 to 640) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social functioning: clinically important change ‐ not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Leaving the study early: any reason<br/>assessed by: number of dropouts for any reason </p> <p>Study duration: 4 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.51<br/>(0.73 to 8.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>79<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/>(61 to 716) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PANSS</b> : the Positive and Negative Syndrome Scale; <b>RBANS</b> : the Repeatable Battery for the Assessment of Neuropsychological Status; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by two levels: high risk of bias in two domains (selective reporting, other bias) and unclear risk in one domain (blinding of participants and personnel). </p> <p><sup>2</sup> Downgraded by two levels: the optimal information size (OIS) was not met and the confidence interval included both appreciable benefit and harm. </p> <p><sup>3</sup> Downgraded by one level: OIS was not met. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Magnetic seizure therapy plus standard care compared to electroconvulsive therapy plus standard care for people with schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/full#CD012697-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012697-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Global state: clinically important change  ‐ number of participants with clinical response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Adverse effects: clinically important  adverse effects ‐ number of participants with a delayed memory deficit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Cognitive functioning: any change ‐ number of participants with improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Cognitive functioning: average change score from baseline to endpoint of RBANS total index (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Mental state‐Overall: average change score from baseline to endpoint of PANSS total (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Mental state‐Positive symptoms: average change score from baseline to endpoint of PANSS positive subscale (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Mental state‐Negative symptoms: change scores of PANSS negative subscale (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Leaving the study early: any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Leaving the study early: due to adverse effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Leaving the study early: due to inefficacy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Magnetic seizure therapy plus standard care verus electroconvulsive therapy plus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012697.pub2/references#CD012697-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012697.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012697-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012697-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012697-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="id#CD012697-note-0011">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD012697-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD012697-note-0006">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD012697-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012697-note-0012">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD012697-note-0007">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012697-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012697-note-0005">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012697\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012697\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012697\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012697\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=XHP2gG4h&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012697.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012697.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012697.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012697.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012697.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719045269"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012697.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719045273"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012697.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddf220e801be4',t:'MTc0MDcxOTA0NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 